CAS 1613200-51-3

Tuvusertib

CAS: 1613200-51-3

Tuvusertib

Purity: ≥98%

Molecular weight: 370.32g/mol

Ref: 54-BUP02405

2-Amino-6-fluoro-N-[5-fluoro-4-(1-methyl-1H-imidazol-5-yl)-3-pyridinyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide

CAS: 1613200-51-3

2-Amino-6-fluoro-N-[5-fluoro-4-(1-methyl-1H-imidazol-5-yl)-3-pyridinyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide is an inhibitor of viral RNA synthesis. It is a potent inhibitor of the human immunodeficiency virus type 1 (HIV) reverse transcriptase and has been shown to reduce the production of HIV in vitro. 2AFNPYPC is also active against hepatitis B virus (HBV). This drug binds to the active site of HIV reverse transcriptase and HBV polymerase, respectively. The binding affinity for these two enzymes is similar, suggesting that this drug may be effective against other viruses with a similar enzyme target.

Formula: C₁₆H₁₂F₂N₈O

Purity: Min. 95%

Molecular weight: 370.32 g/mol

Ref: 3D-NPC20051

Tuvusertib

CAS: 1613200-51-3

Tuvusertib (M1774), an oral ATR inhibitor (Ki<1µM), selectively blocks CHK1 phosphorylation, disrupts DNA repair, and induces tumor cell apoptosis.

Formula: C₁₆H₁₂F₂N₈O

Purity: 98.44% - 99.66%

Color and Shape: Solid

Molecular weight: 370.32

Ref: TM-T10406